Loader

Pathways

PathWhiz ID Pathway Meta Data

PW145677

Pw145677 View Pathway
drug action

Silodosin Drug Metabolism Action Pathway

Homo sapiens

PW146759

Pw146759 View Pathway
drug action

Silodrate Drug Metabolism Action Pathway

Homo sapiens

PW146574

Pw146574 View Pathway
drug action

Silver Drug Metabolism Action Pathway

Homo sapiens

PW146220

Pw146220 View Pathway
drug action

Silver nitrate Drug Metabolism Action Pathway

Homo sapiens

PW132182

Pw132182 View Pathway
metabolic

Silver sulfadiazine Drug Metabolism

Homo sapiens
Silver sulfadiazine is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Silver sulfadiazine passes through the liver and is then excreted from the body mainly through the kidney.

PW145633

Pw145633 View Pathway
drug action

Silver sulfadiazine Drug Metabolism Action Pathway

Homo sapiens

PW127522

Pw127522 View Pathway
drug action

Simeprevir Action Pathway

Homo sapiens
Simeprevir is a direct-acting antiviral agent that inhibits HCV NS3/4A protease to treat chronic hepatitis C virus (HCV) infection in adults with HCV genotype 1 or 4. Hepatitis C virus lipoviroparticles enter target hepatocytes via receptor-mediated endocytosis. The lipoviroparticles attach to LDL-R and SR-B1, and then the virus binds to CD81 and subsequently claudin-1 and occludin, which mediate the late steps of viral entry. The virus is internalized by clathrin-dependent endocytosis. RNA is released from the mature Hepatitis C virion and translated at the rough endoplasmic reticulum into a single Genome polyprotein. Simeprevir accumulates in the liver after uptake into hepatocytes via solute carrier organic anion transporter family member 1B1. Simeprevir inhibits NS3/4A protease, which is an enzyme that cleaves the heptatitis C virus polyprotein downstream of the NS3 proteolytic site, which generates nonstructural proteins NS3, NS4A, NS4B, NS5A, and NS5B. These proteins are required in viral RNA replication, therefore because of the inhibition of their formation, RNA replication cannot occur. Because RNA replication does not occur, the mature virion is unable to form. At higher concentration above their antiviral half-maximal effective concentration (EC50), simeprevir and other NS3/4A inhibitors also restore interferon (IFN)-signaling pathways that are thought to be disrupted by NS3/4A protease and recover innate immune processes. NS3/4A protease cleaves two essential adaptor proteins that initiate signaling leading to activation of IFN regulatory factor 3 and IFN-α/β synthesis, which are mitochondrial antiviral-signaling proteins.

PW145703

Pw145703 View Pathway
drug action

Simeprevir Drug Metabolism Action Pathway

Homo sapiens

PW132193

Pw132193 View Pathway
metabolic

Simethicone Drug Metabolism

Homo sapiens
Simethicone is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Simethicone passes through the liver and is then excreted from the body mainly through the kidney.

PW146182

Pw146182 View Pathway
drug action

Simethicone Drug Metabolism Action Pathway

Homo sapiens